Ch. 15
Specific Defenses of the Host
Specific immunity
 When the non-specific defense fails, then the third, specific line of immunity is activated
 Immunity is not innate but adaptive; it is acquired over time
 It is characterized with a specificity and memory
 Specificity  antibodies against chickenpox is not effective against measles virus
 During the 2nd encounter with a pathogen, the lymphocytes recall the 1st engagement and attack it again
 Immunity is a defensive response of the body when a foreign organism or foreign substance invades it.
 Antigens are substances (proteins or polysaccharides) that provoke immune response
 Antibodies are proteins produced to inactivate the antigens
 During the immune response, lymphocytes recognize and bind to the antigen
 The immune system has two components:
1. Humoral immunity  production of
antibodies (B-cells)
2. Cell-mediated immunity  activation and proliferation of immune system cells (T-cells)
Overview of lymphocyte development and interaction
There are 5 Stages:
Development of B-cells and T-cells
Antigen presenting cells present the antigen to lymphocytes (T-helper cells)
Lymphocytes activation  formation of B and T cells
B lymphocytes become plasma cells  produce antibodies
Activated T cells become Helper T cells and cytotoxic T cells
Specificity of the lymphocytes
 They have receptor sites on the cell surface that can recognize millions of different antigens
 This great diversity of receptor sites is achieved through genetic recombination of 500 genes
 The lymphocytes with the receptor sites for self cells are eliminated
 Upon entry of an antigen, only lymphocytes specific to that antigen proliferate  clonal selection
Characteristics of Antigens
 Not a normal constituent of the body
 They are components of microbial cells (capsule, cell wall, flagella, fimbriae, microbial toxins, and coats of viruses), humans, plants, animals
 They belong to: proteins, lipoproteins, glycoproteins
 Good antigens have complex molecules
 Poor antigens have small and simple molecules
 Antigens contain specific regions that are recognized by antibodies  antigenic determinants or epitopes
 Superantigens (bacterial toxins) can trigger a 100 times greater response of immune system  toxic shock syndrome
Antigen Processing and Presentation
 Antigen Processing
 Antigen Processing Cells (APC) ingest a bacterial cell  degrade the antigen into smaller peptides
 The processed antigens are complexed with a cell glycoprotein MHCII (major histocompatibility complex)  and transported to the cell surface
 Antigen Presentation
 The processed antigens are presented to lymphocytes
 T cells are activated  they release interleukin-2
B-cell activation and antibody synthesis
 The linked receptor of T-cells and B-cells, and chemical stimulus from the T-cell  stimulates the B-cells
 Proliferation and differentiation of B-cells
 Two types of cells are formed: memory cells and plasma cells
 Memory cells play role in future exposure to the same antigen
 Plasma cells  synthesize and release the antibodies
Antibody Structure
 Antibodies are specific proteins (immunoglobulins  Ig) developed by the body that is invaded by a specific microorganism
 The antibody molecule is Y-shaped. It consists of 4 protein chains:
 2 identical heavy chains
 2 identical light chains
 Each antibody molecule has two binding sites (site that binds to antigen)
 Antibody molecule is made up of
 constant region
 variable region
 binds the epitope of the antigen
Antibody-Antigen Interactions
 Complementary fit between antigen and antibody is needed
 The better the fit the better the stimulation of the lymphocytes
Antigen - Antibody Binding
Antigens are rendered harmless by different mechanisms:
|  | Agglutination - antibodies cross-link the antigens (bacterial cells) forming aggregates that are more easily digested by phagocytes | 
 Opsonization - antibodies coat the antigens enhancing the phagocytosis
 Neutralization - antibodies block the active sites on viruses (or bacteria) preventing their attachment to host cells
Immunoglobulin classes
 IgG  80% of all antibodies; effective against bacteria, toxins, trigger the complement system, long term immunity
 IgA - Abundant in mucus membranes
 IgM  Large molecule, first to appear, circulate in blood
 IgD  In small amounts (1%) has no well-defined function, B-cell activation
 IgE - Play role in allergic reactions
Primary and Secondary Responses to Antigen
 Primary response
 There is a latent period
 Takes longer to reach the maximum
 Secondary response
 Memory cells responsible
 Fast response
 Higher concentration of immunoglobulins
 Basis for vaccination
T cells and cellular immunity
 Produced in the bone marrow, mature in thymus gland, and wait for the encounter with antigens in the lymphoid organs
 Two populations of T cells:
 Helper T cells (with CD4 receptor)
 Cytotoxic T cells
 Recognize peptides that are presented on dendritic cells
Helper Cells
 Activated helper cells produce cytokins  Th cells proliferate and produce
 cytotoxic T cells
 natural killer cells
 macrophages
 Depression of T cell (class CD4) by HIV is responsible for pathology of AIDS
Cytotoxic T Cell
 Recognize and kill the infected cell (some microorganisms multiply inside the host cell)
 Recognize and kill nonself (tumor) cells
 Attaches to the target cell and releases perforin (pore-forming protein)
Natural Killer Cells
 Lymphocytes related to T cells
 They do not have specificity for antigen
 The first to attack cancer cells and virus infected cells
Classifying Specific Immunity
 Natural active immunity
 Getting the infection
 Natural passive immunity
 Maternal antibodies are transported across placenta
 Artificial Active Immunity
 Vaccination
 Artificial Passive Immunity (Immunotherapy)
 Administration of specific antibody  obtained by vaccinating animals and extracting the serum
Monoclonal Antibodies
Technique by which large amounts of specific antibodies can
be produced
Vaccines
 Vaccine is a suspension of microorganisms or their cell components that are injected into a human or animal body in order to induce immunity.
 The purpose of vaccination is to control microbial diseases and to prevent epidemics
Types of vaccines
Attenuated whole agent vaccine
 Use of living but attenuated (weakened) or mutant microbes. Measles, mumps, rubella (MMR)
 Advantage: more closely mimic an actual infection
 Disadvantage: can backmutate to virulent form and cause a disease
Inactivated whole-agent vaccines
 Use of killed microbes (rabies, influenza, and polio)
 Killed by formalin or phenol
Toxoids
 Chemically or thermally modified toxins used to stimulate active immunity
 Tetanus, diphtheria toxoids  requires series of injections
 Require boosters every 10 years
Recombinant vaccines
 Genetically engineered microorganisms produce the antigenic fraction of the pathogen (Hepatitis B).
DNA vaccine
 Promising technology in vaccine production
 Gene coding for an antigen is incorporated into a plasmid  naked DNA (plasmid) injected
 Human cells will take up the plasmid
 Foreign protein (antigen) will be expressed
 This will stimulate immune response
Why to Vaccinate?
 To protect individuals
 To establish herd immunity
 Protection of the whole population
 Prevention of epidemics
 Protection of non-immunized individual